Grow Your Pharma Business Digitally
Virtual Booth
Contact Supplier
An Enquiry
Product Reset all filters
01 1Talzenna
Talazoparib Tosylate
Pfizer Inc.
Main Therapeutic Indication : Oncology
Currency : USD
2024 Revenue in Millions : 117
2023 Revenue in Millions : 64
Growth (%) : 83
Portfolio PDF
Product Web Link
Digital Content
Website
Corporate PDF